Literature DB >> 2992092

Recombinant vaccinia virus: immunization against multiple pathogens.

M E Perkus, A Piccini, B R Lipinskas, E Paoletti.   

Abstract

The coding sequences for the hepatitis B virus surface antigen, the herpes simplex virus glycoprotein D, and the influenza virus hemagglutinin were inserted into a single vaccinia virus genome. Rabbits inoculated intravenously or intradermally with this polyvalent vaccinia virus recombinant produced antibodies reactive to all three authentic foreign antigens. In addition, the feasibility of multiple rounds of vaccination with recombinant vaccinia virus was demonstrated.

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2992092     DOI： 10.1126/science.2992092

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  39 in total

1.  Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector.

Authors:  J C Ramírez; M M Gherardi; D Rodríguez; M Esteban
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

Review 2.  New therapeutic vaccination strategies for the treatment of chronic hepatitis B.

Authors:  Jia Liu; Anna Kosinska; Mengji Lu; Michael Roggendorf
Journal:  Virol Sin       Date:  2014-01-17       Impact factor: 4.327

3.  Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.

Authors:  M E Perkus; K Limbach; E Paoletti
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  A tandemly-oriented late gene cluster within the vaccinia virus genome.

Authors:  S L Weinrich; D E Hruby
Journal:  Nucleic Acids Res       Date:  1986-04-11       Impact factor: 16.971

Review 5.  Use of vaccinia virus to express biopharmaceutical products.

Authors:  D E Hruby; G Thomas
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

6.  Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules.

Authors:  Claudia Palena; Kenneth A Foon; Dennis Panicali; Alicia Gómez Yafal; Jarasvech Chinsangaram; James W Hodge; Jeffrey Schlom; Kwong Y Tsang
Journal:  Blood       Date:  2005-08-04       Impact factor: 22.113

7.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Differences in virus-induced cell morphology and in virus maturation between MVA and other strains (WR, Ankara, and NYCBH) of vaccinia virus in infected human cells.

Authors:  Juan Carlos Gallego-Gómez; Cristina Risco; Dolores Rodríguez; Pilar Cabezas; Susana Guerra; José L Carrascosa; Mariano Esteban
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  M protein (M1) of influenza virus: antigenic analysis and intracellular localization with monoclonal antibodies.

Authors:  D Bucher; S Popple; M Baer; A Mikhail; Y F Gong; C Whitaker; E Paoletti; A Judd
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

10.  Novel recombinant parapoxvirus vectors induce protective humoral and cellular immunity against lethal herpesvirus challenge infection in mice.

Authors:  Timo Fischer; Oliver Planz; Lothar Stitz; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.